1 |
neuroblastoma RAS viral oncogene homolog
(58 times)
|
Neoplasms (24 times)
|
KRAS (18 times) EGFR (13 times) CRC (10 times)
|
2008 Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia.
|
2 |
neuroblastoma RAS
(12 times)
|
Medicine (3 times)
|
KRAS (5 times) RAS (5 times) BRAF (2 times)
|
2006 Examination of mutations in BRAF, NRAS, and PTEN in primary cutaneous melanoma.
|
3 |
neuroblastoma rat sarcoma oncogene
(10 times)
|
Neoplasms (6 times)
|
KRAS (4 times) EGFR (2 times) MAPK (2 times)
|
2013 Combined targeting of MEK and PI3K/mTOR effector pathways is necessary to effectively inhibit NRAS mutant melanoma in vitro and in vivo.
|
4 |
neuroblastoma rat sarcoma
(5 times)
|
Neoplasms (4 times)
|
PDX (2 times) AML (1 time) BM (1 time)
|
2016 Phosphoproteomic Analyses of NRAS(G12) and NRAS(Q61) Mutant Melanocytes Reveal Increased CK2alpha Kinase Levels in NRAS(Q61) Mutant Cells.
|
5 |
NRAS proto-oncogene, GTPase
(5 times)
|
Neoplasms (3 times)
|
BRAF (3 times) KRAS (2 times) ASXL1 (1 time)
|
2017 Unique presentation of cutis laxa with Leigh-like syndrome due to ECHS1 deficiency.
|
6 |
National Registration and Accreditation Scheme
(4 times)
|
Health Services (2 times)
|
AHPRA (2 times)
|
2015 Approaches to management of complaints and notifications about health practitioners in Australia.
|
7 |
National Rheumatoid Arthritis Society
(3 times)
|
Orthopedics (2 times)
|
RA (3 times) CPRD (1 time) HU (1 time)
|
2008 Exploring the healthcare journey of patients with rheumatoid arthritis: a mapping project - implications for practice.
|
8 |
Neonatal Resuscitation and Adaptation Score
(3 times)
|
Child (1 time)
|
---
|
2015 Evaluation of a Comprehensive Delivery Room Neonatal Resuscitation and Adaptation Score (NRAS) Compared to the Apgar Score: A Pilot Study.
|
9 |
non-risk-adapted active surveillance
(3 times)
|
Urology (1 time)
|
AS (1 time) CSI (1 time) CSITC (1 time)
|
2018 Non-risk-adapted Surveillance for Stage I Testicular Cancer: Critical Review and Summary.
|
10 |
nonrenin-angiotensin system
(3 times)
|
Gastroenterology (1 time)
|
RAS (3 times) Ang I (1 time)
|
1993 Levels of angiotensin and molecular biology of the tissue renin angiotensin systems.
|
11 |
national resilience assessment scale
(1 time)
|
Psychology (1 time)
|
---
|
2019 National Resilience: A New Self-Report Assessment Scale.
|
12 |
near reflex accommodation spasm
(1 time)
|
Neurology (1 time)
|
---
|
2002 Near reflex accommodation spasm: unusual presentation of generalized photosensitive epilepsy.
|
13 |
neoroblastoma
(1 time)
|
Neoplasms (1 time)
|
HCC (1 time) ICC (1 time) KRAS (1 time)
|
2018 Primary Liver Cancers, Part 2: Progression Pathways and Carcinogenesis.
|
14 |
neuroblastoma RAS homolog
(1 time)
|
Medicine (1 time)
|
CDK4 (1 time) MEK (1 time)
|
2012 Oncogenic NRAS signaling differentially regulates survival and proliferation in melanoma.
|
15 |
neuroblastoma ras oncogene
(1 time)
|
Pathology (1 time)
|
BRAF (1 time) cfDNA (1 time) ctDNA (1 time)
|
2020 Construction of a reference material panel for detecting KRAS/NRAS/EGFR/BRAF/MET mutations in plasma ctDNA.
|
16 |
Neuroblastoma Rat Sarcoma Virus
(1 time)
|
Molecular Biology (1 time)
|
---
|
2012 NRAS mutant melanoma: biological behavior and future strategies for therapeutic management.
|
17 |
neuroblastoma rat-sarcoma homolog
(1 time)
|
Dermatology (1 time)
|
---
|
2016 Searching for the Chokehold of NRAS Mutant Melanoma.
|
18 |
neuroblastoma-type ras sarcoma virus
(1 time)
|
Neoplasms (1 time)
|
NCSCs (1 time)
|
2020 Decoding the Role of CD271 in Melanoma.
|